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Curcuminoid, a mixture compound of curcumin, 
demethoxycurcumin, and bisdemethoxycurcumin, is 
widely known as a functional food and is obtained from 
the isolation of turmeric (Curcuma longa) rhizome and 
other species of Zingiberaceae. Extensive investigations 
revealed the beneficial effects of curcumin to cure 
several diseases with its main activities as antioxidant 
and anti-inflammation (Basnet & Skalko-Basnet, 2011; 
Abdollahi et al., 2017). Although extensive in vitro and in 
vivo studies highlighted the potential activities of 
curcumin, a clear therapeutic benefit of curcumin in 
clinical studies remained questionable due to the poor 
bioavailability of curcumin after oral administration 
(Gupta, Patchva & Aggarwal, 2012). The poor 
bioavailability of curcumin has been attributed to the 
low aqueous solubility and dissolution; the solubility of 
curcumin in water was reported to be 11 ng/mL (Wang 
et al., 1997).  
An increased dissolution has been proposed to tackle the 
bioavailability problem of curcumin. Solid dispersion is 
one of the potential strategies to improve curcumin 
dissolution. Several factors enhance the dissolution rate 
of drugs, including increased surface area by reducing 
particle size, improvement of wetting, reduced 
agglomeration, and increased saturated concentration 
resulting from the amorphous form (Craig, 2002). 
Different types of carriers and methods are used to 
prepare solid dispersions (Leuner & Dressman, 2000). 
One of the carriers used in solid dispersion preparation 
is the poloxamer, a non-ionic triblock copolymer of 
polyoxyethylene-polyoxypropylene-polyoxyethylene, 
which has surfactant properties (Bodratti & Alexandridis, 
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Introduction: Curcumin, a BCS II drug, suffers from poor bioavailability. Increasing 
curcumin dissolution is a way to increase its bioavailability. Solid dispersion formulation 
can be used to improve curcumin dissolution. However, the successful curcumin solid 
dispersion is limited to a relatively low drug load (< 20%).     Aim: This study aimed to 
investigate the dissolution behaviour of curcumin at a higher drug load (27.9%, 42.3%, 
and 56.6%) using a surfactant carrier of poloxamer 407.    Methods: The solvent 
evaporation method was employed to prepare high drug load solid dispersion of 
curcumin. A physical mixture of the corresponding solid dispersion formulation was 
prepared as a control. Drug load, dissolution behaviour in 180 minutes, and dissolution 
efficiency (DE180) were determined.   Results: The results showed that incorporating 
curcumin into a poloxamer 407 solid dispersion significantly improves the dissolution rate 
of curcumin. In the solid dispersion formula, the dissolution behaviour of curcumin was 
found to be carrier-dependent. 
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solid dispersion is achieved by improving the wettability 
and the ability of intermolecular interaction of 
poloxamer-drug to form a molecular dispersion (Ali, 
Williams & Rawlinson, 2010). This work aimed to 
investigate the dissolution behaviour of curcumin at a 
higher drug load (above 20% to less than 60%), using a 
surfactant carrier of poloxamer 407.  
 
Material and Method 
Material 
Curcuma longa standardised extract (84.67% curcumin 
as detected by spectrophotometric method) was given 
by PT Phytochemindo Reksa, Bogor, Indonesia. 
Curcumin standard compound was purchased from 
Sigma. The poloxamer 407 was given by PT Konimex, 
Solo, Indonesia. Citric acid, methanol, ethanol, sodium 
dihydrogen phosphate dihydrate, and sodium lauryl 
sulfate (SLS) were purchased from Merck. Capsule 
shells of the size of 00 were purchased from Kapsulindo 




1. Preparation of the solid dispersion formulation  
The poloxamer 407 based solid dispersion (SD-PC) was 
prepared at 27.9%, 42.3%, and 56.6-wt % of the C. 
longa extract by a solvent evaporation method using a 
vacuum rotary evaporator. The formulas were coded as 
SD-PC 33, SD-PC 50, and SD-PC 67 assigned to each 
extract -wt. % of 27.9%, 42.3%, and 56.6-wt %, 
respectively in the solid dispersion formulations. 
Briefly, an accurate weight of C. longa extract and 
poloxamer 407 according to each code of formula was 
dissolved in ethanol at concentrations of 5 mg/mL and 
45 mg/mL. Both solutions were stirred for 30 minutes 
to form a clear yellow solution. The ethanol was 
evaporated using a BUCHI vacuum rotary evaporator at 
80⁰C. The obtained viscous solution was then 
subsequently dried using a vacuum oven. The dried 
product was pulverized in a mortar and sieved using a 
60-mesh size. Physical mixture formulations (PM-PC) 
were prepared at the drug load as that prepared in the 
SD-PC formulations. The extract and poloxamer 407 
were gently mixed in a mortar using a spatula and 
sieved using a 60-mesh size. For the dissolution study, 
the SD powder was prepared into an approximately 500 
mg capsule of size 00. The drug load of curcumin in the 
SD formulations was quantified using the calibration 
curve prepared from the serial concentrations of 
curcumin reference standard in methanolic solution. 
The linearity between the concentration and the 
absorption was confirmed with y=0.1349x + 0.0035 and 
a correlation coefficient of 0.9972.  
 
2. Dissolution 
The dissolution of the SD-PC or PM-PC prepared in 
capsules was evaluated using a SOTAX AT7 dissolution 
tester according to the USP type II dissolution method. 
For the dissolution study of lipophilic compounds like 
curcumin, 0.5% surfactant of SLS was added into 20 
mM sodium phosphate buffer of pH 6.0. This pH value 
was chosen because the curcumin solution is highly 
stable at pH 6.0 (Wang et al., 1997). The dissolution was 
carried out in 900 mL media with a paddle speed of 100 
rpm and a temperature of 37±0.5°C. The samples of 2 
mL were taken at predetermined time intervals of 0, 10, 
15, 30, 45, 60, 90, 120, and 180 minutes. The 
withdrawn volume was replaced with the same volume 
of a fresh dissolution medium, maintained at 37° to 
keep the volume and sink condition constant. Curcumin 
in the dissolution sample was determined using the 
validated spectroscopic method at 430 nm against the 
blank sample of the dissolution medium. Curcumin 
concentrations were quantified based on the 
calibration curve at which the result shows linearity 
with a linear equation of y=0.1279x + 0.009 and a 
relation coefficient of 0.997.  
 
3. Data analysis 
The dissolution profile was determined by calculating 
the Dissolution Efficiency (DE) at 180 min, as in 
equations 1 and 2. The area under the curve of 
dissolved curcumin was calculated by the trapezoidal 








) × 100% AUC =  ∑





Equation 1 Equation 2 
DEt : Dissolution efficiency at time (t) 
y : Area under the curve of dissolved drug at time t 
y100.t : Rectangle area where 100% of drug dissolved at time t 
 
Results  
Table I shows the amount of curcumin content in the 
solid dispersion and physical mixture formulations. 
The % assay values, calculated based on the recovery at 
which the obtained curcumin contents were divided by 
the theoretical values and multiplied by 100%, were 
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between 94.33-99.48% for SD-PC and PM-PC 
formulations. The curcumin content for all SD and PM 
formulations was calculated for the relative standard 
deviation (RSD) values. The RSD values for all SD and PM 
formulations are between 0.12%-4.50%. 
 
Table I: Curcumin content was observed in the solid dispersion (SD) and physical mixture 
% weight of C. longa 
extract 
Code SD-PC Code PM-PC 
 % found % assay RSD  % found % assay RSD 
27.9 SD-PC 33 27.59 ± 0.38 99.24 1.37 PM-PC 33 27.42 ± 0.32 99.48 1.16 
42.3 SD-PC 50 40.87 ± 0.67 96.54 1.63 PM-PC 50 41.22 ± 0.71 96.38 1.72 
56.6 SD-PC 67 56.29 ± 0.07 99.38 0.12 PM-PC 67 53.52 ± 2.41  94.33 4.50 
Note: Data were presented as mean and SD of 3 assays. % assay was calculated by dividing the observed amount of curcumin by the theoretical 
amount of curcumin present in the formulation at the accordingly wt % of C. longa extract. The theoretical amount of curcumin was determined 
based on the curcumin content in the standardized C. longa extract.   
 
The in vitro dissolution profile of the different solid 
dispersion formulations using poloxamer 407 and the 
respective physical mixture in 20 mM sodium phosphate 
buffer of pH 6.0 are shown in Figure 1 (a, b, and c). At the 
end of 180 minutes, 26.62%, 18.38%, 12.22%, 41.18%, 
23.41%, and 21.92% were released from PM-PC 33, PM-PC 
50, PM PC 67, SD-PC 33, SD-PC 50, and SD PC 67, 
respectively. The dissolution profile of SD and PM 
formulation show stagnant dissolution rate after 30 
minutes (SD/PM-PC 33), 45 minutes (SD/PC-50), and 60 
(SD/PC-PC 67). 
DE180 was used to compare the dissolution profiles resulting 
from all SD and PC formulations and presented in Figure 1d, 
showing that all SD formulations increased the dissolution 
rate of curcumin compared to the physical mixture 
formulation as monitored in 180 minutes. It also revealed 
that the solid dispersion formulation increased the 
dissolution rate of curcumin as compared to the 





Figure 1: Dissolution behaviour of curcumin from SD and PM formulations 
SD-PC/PM-PC 33 SD-PC/PM-PC 50 
SD-PC/PM-PC 67 Dissolution efficiency  
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As shown in Table I, the RSD values for SD and PM 
formulations are all below 5%. The data indicate that the 
solid dispersion and physical mixtures formulations are 
homogenous; independent assays of three samples taken 
from any dispersion showed an even drug distribution 
within each system. All formulas showed that % values 
between the founded curcumin content and the 
theoretical curcumin concentration were close, as 
reflected by a high % assay values of between 90 and 
100%. Moreover, curcumin content in the SD-PC is quite 
close to the PM-PC, indicating that the curcumin remains 
preserved during the preparation processes of the solid 
dispersion formulations.  
Surfactants can improve the hydrophobicity of poorly 
water-soluble drugs and increase the dissolution rate by 
increasing wettability. Solid dispersion formulation of C. 
longa extract using poloxamer 407 as carrier improves the 
dissolution profile of curcumin compared to the physical 
mixture formulation (Figure 1a, b, c) due to the 
improvement of wetting with the addition of poloxamer 
407. A significant increase in dissolution rate was observed 
from the SD-PC 33 and SD-PC 67 compared to the 
corresponding physical mixture formulation (PM-PC 33 
and PM-PC 67). The dissolution rate declined as higher 
extract concentration in the solid dispersion formulations 
was used (SD-PC 67). The release of curcumin during 180 
minutes was about 40%; however, at higher extract 
concentration (SD-PC 67), the dissolution decreased to 
20%. A lower dissolution rate at a higher drug load was 
also reported by other publications, suggesting that the 
dissolution mechanism is controlled by the carrier. 
Dissolution efficiency (DE) is a dissolution parameter used 
to compare characteristics of the dissolution profile 
between formulas. The effect of increasing extract 
content in the solid dispersion formulation markedly 
reduced the dissolution rate of curcumin, as indicated by 
the DE values (Figure 1d). Lowering the dissolution rate by 
increasing the extracted content was observed in the solid 




Poloxamer 407 is an effective carrier to increase the 
dissolution rate of curcumin during a 180-minute study in 
solid dispersion formulations containing C. 
longa standardized extract. An increased extracted 
content in the solid dispersion formulation results in 
reduced dissolution of curcumin dissolution. The highest 
dissolution rate of curcumin is found in the extracted 
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